Hubungan Polimorfisme Gen Matriks Metaloproteinase-12 Dengan Kejadian Penyakit Paru Obstruktif Kronik Dibandingkan Dengan Non Penyakit Paru Obstruktif Kronik
DAFTAR PUSTAKA
American Lung Association State of Lung Disease in Diverse Communities. 2010.
Chronic Obstructif Pulmonary Disease COPD: 35-39.
Arja, C., Ravuri. R.R., Pulamaghatta. V.N., Surapaneni., K.M., Raya, P., Adimoolam,
C., dan Kanala, K.R. 2014. Genetic Determinants of Chronic Obstructive
Pulmonary Disease in South Indian Male Smokers. Plos One, Volume 9, Nomor
2: e89957.
Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan Republik
Indonesia (RI). 2013. Laporan Riset Kesehatan Dasar (RISKESDAS). Updated
Desember 2014.
Cai, J., Wang, L., dan Wang, A. 2010. MMP-1 Gene Polymorphism and COPD
Susceptibility in Han Nationality in Jiangxi Province. Shandong Medical
Journal, Volume 50: 77.
Chaudhary, A,K., Singh, M., Bharti, A.C., Asotra K., Sundaram, S., dan Mehrotra R.
2010. Genetic Polymorphisms of Matrix Metalloproteinases and Their Inhibitors
in Potentially Malignant and Malignant Lesions of The Head and Neck. Journal
of Biomedical Science, Volume 17, Nomor 10: 2-5.
Universitas Sumatera Utara
Cheng, S.L., Yu, C.J., dan Yang, P.C. 2009. Genetic Polymorphism of Cytochrome
p450 and Matrix Metalloproteinase in Chronic Obstructive Pulmonary Disease.
Biochem Genet, Volume 47: 600.
Churg, A., Zhou, S., dan Wright, J.L. 2012. Matrix Metalloproteinases in COPD. Eur
Respir J, Volume 39: 197-209.
CAT Development Steering Group. COPD Assessment Test (CAT) User Guide. 2009.
Last
updated:
February
24,
2012.
Available
from
:http://www.catestonline.org/images/UserGuides/CATHCPUser%20guideEn.pdf
Depkes RI. 2007. Survei Sosial Ekonomi Nasional (SUSENAS). Profil Kesehatan
Indonesia.
Enewold, L., Mechanic, L.E., Bowman, E.D., Platz, E.A., dan Alberg, A.J. 2012.
Association of Matrix Metalloproteinase-1 Polymorphism with Risk of COPD
and Lung Cancer and Survival in Lung Cancer.Anticancer Res, Volume 32:
3920.
Global Initiative for Chronic Obstructive Lung Disease. Revised 2011. Global Strategy
for the Diagnosis, Management, and Prevention of Chronic Obstructive
Pulmonary Disease: 1-7.
Universitas Sumatera Utara
Han, W., Kuang, J., dan Rao, W. 2010. MMP-9 Polymorphisms and Susceptibility to
Chronic Obstructive Pulmonary Disease. Chin J Tuberc Respir Dis, Volume 29:
278.
Haq, I., Chappel, S., Johnson, S.R., Lotya, J., Daly, L., Morgan, K., Guetta-Baranes, T.,
Roca, J., Rabinovich, R., Millar, A.B., Donnelly, S.C., Keatings, V., MacNee,
W., Stolk, J.,Hiemstra, P.S., Miniati, M., Monti, S., O’Connor, C.M., dan
Kalsheker, N. 2010. Association of MMP-12 Polymorphisms with Severe and
Very Severe COPD: A Case Control Study of MMPs-1, 9 and 12 in a European
Population. BMC Medical Genetics, Volume 11, Nomor 7: 1-11.
Hersh, C.P., DeMeo, D.L., Lazarus, R., Celedon, J.C., Raby, B.A., Benditt, J.O., Criner,
G., Make, B., Martinez F.J dan Scanlon, P.D.2006. Genetic Association
Analysis of Functional Impairment in Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med, Volume 173, Nomor 9: 982.
http://www.had2know.com/academics/hardy-weinberg-equilibrium-calculator-2alleles.html. Last updated Desember, 2014.
Hudoyo, A, Sp.P. Edisi Revisi 2011. Penatalaksanaan Asma dan PPOK Pada Orang
Dewasa Berdasar Pedoman GINA (Global Initiative for Asthma) & GOLD
(Global initiative for Chronic Obstructive Lung Disease): 1-9.
Hunninghake, G.M., Cho, M.H., Tesfaigzi, Y., Soto-Quiros, M.E., Avila, L., Lasky-Su,
J., Stidley, C., Melen E., Soderhall, C., Hallberg, J., Kull, I., Kere, J.,
Universitas Sumatera Utara
Svartengren, M., Pershagen, G., Wickman, M., Lange, C., Demeo, D.L., Hersh,
C.P, Klanderman, B.J., Raby, B.A., Sparrow, D., Shapiro, S.D., Silverman, E.K.,
Litonjua, A.A., Weiss, S.T., dan Celedon, J.C. 2009. MMP12, Lung Function,
and COPD in High-Risk Population. The New England Journal of Medicine: 2,
8.
Ishii, T., Matsuse, T., Teramoto, S., Matsui, H., Miyao, M., Hosoi, T., Takahashi, H.,
Fukuchi, Y., dan Ouchi, Y. 2006. Glutathione S-transferase P1 (GSTP1)
Polymorphism in Patients with Chronic Obstructive Pulmonary Disease. Thorax,
Volume 54: 693-696.
Ito, I. et al. 2008. Matrix Metalloproteinase-9 Promoter Polymorphism Associated With
Upper Lung Dominant Emphysema. Am J Respir Crit Care Med, Volume 172:
1382.
Joshi, J.M. 2008. Chronic Obstructive Pulmonary Disease: Knowing What We Mean,
Meaning What We Say, Review Article. The Indian Journal of Chest Diseases
& Allied Sciences, Volume 50: 89-95.
Jurnal Respirologi Indonesia. 2007. Penyakit Paru Obstruktif Kronik Sebagai Penyakit
Sistemik: 1-5.
Keputusan Kementerian Kesehatan Republik Indonesia no.1022/Menkes/SK/XI/2008.
Pedoman Pengendalian Penyakit Paru Obstruktif Kronik: 11-15.
Universitas Sumatera Utara
Keputusan Kementerian Kesehatan Republik Indonesia no.1022/Menkes/SK/XI/2011.
Pedoman Pengendalian Penyakit Paru Obstruktif Kronik: 10.
Korytina, G.F., Akhmadishina, L.Z., Ianbaeva, D.G., dan Victorova, T.V. 2008.
Polymorphism in Promoter Regions of Matrix Metalloproteinases (MMP1,
MMP9, and MMP12) in Chronic Obstructive Pulmonary Disease Patients.
Russian Journal of Genetics, Volume 44: 206.
Lee, S.Y. et al. 2010. Polymorphism in Matrix Metalloproteinase-1, -9, and -12 Genes
and The Risk of Chronic Obstructive Pulmonary Disease in a Korean
Population. Respiration, Volume 80: 137.
Li, W., Jin, X., Zhou, Y., Zhu, M., Lin, X.F., Hu, X., Wang,W., Wang, F., dan Jin, G.
2012. Lack of Independent Relationship between The MMP-12 Gene
Polymorphism and Carotid Plaque Susceptibility in The Chinese Han
Population.Vascular Medicine, Volume 17, Nomor 5: 310–316.
Nakamura, H. 2011. Genetics of COPD. Allergology International, Volume 60 : 253254.
Nguyen, S.V., Skarstedt, M., Lofgren, S., Zar, N., Andersson, R.E., Lindh, M.,
Matussek, A., dan Dimberg, J. 2013. Gene Polymorphism of Matrix
Metalloproteinase-12 and -13 and Association with Colorectal Cancer in
Swedish Patients. Anticancer Research, Volume 33: 3247-3250.
Universitas Sumatera Utara
Oemiati, R. 2013. Kajian Epidemiologis Penyakit Paru Obstruktif Kronik (PPOK).
Media litbangkes, Volume 23, Nomor 2: 82-88.
Perhimpunan Dokter Paru Indonesia. 2008. Penyakit Paru Obstruktif Kronik (PPOK)
Pedoman Diagnosis & Penatalaksanaan di Indonesia: 2-6.
Santus, P. et al. 2009. Stromelysin 1 Polymorphism as a New Potential Risk Factor in
Progression of Chronic Obstructive Pulmonary Disease. Monaldi Arch Chest
Dis, Volume 71: 16.
Sastroasmoro, S dan Ismael, S. 2011. Dasar-dasar Metodologi Penelitian Klinis. Jakarta,
Penerbit Sagung Seto: 146-166.
Schirmer, H., da Silva, L.B., Teixeira, P.J.Z., Moreira, J.S., Moreira A.L.S., dan Simon,
D. 2009. Matrix Metalloproteinase Gene Polymorphisms: Lack of Association
With Chronic Pulmonary Disease in a Brazilian Population. Genetic and
Molecular Research: Volume 8: 1030-1031.
Sekhon, B.P. 2010. Matrix Metalloproteinases-an overview. Dove Medical Press,
Research and Reports in Biology, Volume 1: 1-20.
Universitas Sumatera Utara
Song, Y., Xie, Y., Liu, F., Zhao, C., Yu, R., Ban, S., Ye, Q., Wen, J., Wan, H., Li, X.,
Ma, R., dan Meng, Z. 2013. Expression of Matrix Metalloproteinase-12 in
Aortic Dissection. BioMed Central Cardiovascular Disorders: Volume 13: 3-9.
Sun, C., Wang, W., Yang, J., Siqingaowa, dan Wang, L. 2012. The Association of
Matrix metalloproteinase 3, 12 Polymorphism with Susceptibility of Chronic
Obstructive Pulmonary Disease. Chin J Clinicians (Electronic Edition), Volume
6: 5829.
Supriyadi, M. 2013. Faktor Genetik Penyakit Paru Obstruktif Kronik. CDK-207,
Volume 40, Nomor 8: 572-578.
Tacheva, T., Dimov., D., Aleksandrova, E., Gulubova, M., dan Vlaykova, T. 2014.
Common Promoter Polymorphism MMP-12 -82A/G in a Population from
Central Bulgaria. Science and Technologies Medicine, Volume 4: 140-143.
Tarigan, A.P. 2012. Hubungan Polimorfisme Gen TNFα Pada Posisi -308 dan -238
Dengan Kejadian Penyakit Paru Obstruktif Kronik. Disertasi, Program Studi
Doktor Ilmu Kedokteran, Universitas Sumatera Utara, Medan.
Teramoto, S. 2007. COPD Pathogenesis from the View Point of Risk Factors. The
Japanese Society of Internal Medicine: 77-78.
Tesfaigzi, Y., Myers, O.B., Stidley, C.A., Schwalm, K., Picchi, M., Crowell, R.E.,
Gilliland, F.D., dan Belinsky, S.A. 2006. Genotypes in Matrix Metalloproteinase
Universitas Sumatera Utara
are a Risk Factor for COPD. Int J Chron Obstruct Pulmon Dis, Volume 1,
Nomor 3: 268.
Van Diemen, C.C. et al. 2011. Genetic Variation in TIMP1 but not MMPs Predict
Excess FEV1 Decline in Two General Population-Based Cohorts. Respir Res,
Volume 12: 57.
Vlaykova, T., dan Dimov, D. 2011. Polymorphisms of Matrix Metalloproteinases
(MMP) in COPD. Biotechnology & Biotechnological Equipment, Volume 26:
116.
Wieczorek, E., Reszka, E., Jablonowski, Z., Jablonska, E., Krol, M.B., Grzegorczyk, A.,
Gromadzinska, J., Sosnowski, M., dan Wasowicz, W. 2013. Genetic
Polymorphisms in Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of
MPs (TIMPs), and Bladder Cancer Susceptibility. BJU International, Volume
112: 1211-1212.
Wood, A.M., Tan, S.L., dan Stockley, R.A. 2009. Review: Chronic Obstructive
Pulmonary Disease: Towards Pharmacogenetics. Genome medicine, Volume 1,
Nomor 112: 1-2,6.
Zitka, O., Kukacka, J., Krizkova, S., Huska, D., Adam, V., Masarik, M., Prusa, R., dan
Kizek, R. 2010. Matrix Metalloproteinase. Current Medicinal Chemistry,
Volume 17: 3751-3768.
Universitas Sumatera Utara
Zhou, H., Wu, Y., Jin, Y., Zhou, J., Zhang, C., Che, L., Jing, J., Chen, Z., Li, W., dan
Shen, H. 2013. Genetic Polymorphism of Matrix Metalloproteinase Family and
Chronic Obstructive Pulmonary Disease Susceptibility: a Meta-analysis.
Scientific Reports, Volume 3, Nomor 2818: 1-8.
Universitas Sumatera Utara
American Lung Association State of Lung Disease in Diverse Communities. 2010.
Chronic Obstructif Pulmonary Disease COPD: 35-39.
Arja, C., Ravuri. R.R., Pulamaghatta. V.N., Surapaneni., K.M., Raya, P., Adimoolam,
C., dan Kanala, K.R. 2014. Genetic Determinants of Chronic Obstructive
Pulmonary Disease in South Indian Male Smokers. Plos One, Volume 9, Nomor
2: e89957.
Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan Republik
Indonesia (RI). 2013. Laporan Riset Kesehatan Dasar (RISKESDAS). Updated
Desember 2014.
Cai, J., Wang, L., dan Wang, A. 2010. MMP-1 Gene Polymorphism and COPD
Susceptibility in Han Nationality in Jiangxi Province. Shandong Medical
Journal, Volume 50: 77.
Chaudhary, A,K., Singh, M., Bharti, A.C., Asotra K., Sundaram, S., dan Mehrotra R.
2010. Genetic Polymorphisms of Matrix Metalloproteinases and Their Inhibitors
in Potentially Malignant and Malignant Lesions of The Head and Neck. Journal
of Biomedical Science, Volume 17, Nomor 10: 2-5.
Universitas Sumatera Utara
Cheng, S.L., Yu, C.J., dan Yang, P.C. 2009. Genetic Polymorphism of Cytochrome
p450 and Matrix Metalloproteinase in Chronic Obstructive Pulmonary Disease.
Biochem Genet, Volume 47: 600.
Churg, A., Zhou, S., dan Wright, J.L. 2012. Matrix Metalloproteinases in COPD. Eur
Respir J, Volume 39: 197-209.
CAT Development Steering Group. COPD Assessment Test (CAT) User Guide. 2009.
Last
updated:
February
24,
2012.
Available
from
:http://www.catestonline.org/images/UserGuides/CATHCPUser%20guideEn.pdf
Depkes RI. 2007. Survei Sosial Ekonomi Nasional (SUSENAS). Profil Kesehatan
Indonesia.
Enewold, L., Mechanic, L.E., Bowman, E.D., Platz, E.A., dan Alberg, A.J. 2012.
Association of Matrix Metalloproteinase-1 Polymorphism with Risk of COPD
and Lung Cancer and Survival in Lung Cancer.Anticancer Res, Volume 32:
3920.
Global Initiative for Chronic Obstructive Lung Disease. Revised 2011. Global Strategy
for the Diagnosis, Management, and Prevention of Chronic Obstructive
Pulmonary Disease: 1-7.
Universitas Sumatera Utara
Han, W., Kuang, J., dan Rao, W. 2010. MMP-9 Polymorphisms and Susceptibility to
Chronic Obstructive Pulmonary Disease. Chin J Tuberc Respir Dis, Volume 29:
278.
Haq, I., Chappel, S., Johnson, S.R., Lotya, J., Daly, L., Morgan, K., Guetta-Baranes, T.,
Roca, J., Rabinovich, R., Millar, A.B., Donnelly, S.C., Keatings, V., MacNee,
W., Stolk, J.,Hiemstra, P.S., Miniati, M., Monti, S., O’Connor, C.M., dan
Kalsheker, N. 2010. Association of MMP-12 Polymorphisms with Severe and
Very Severe COPD: A Case Control Study of MMPs-1, 9 and 12 in a European
Population. BMC Medical Genetics, Volume 11, Nomor 7: 1-11.
Hersh, C.P., DeMeo, D.L., Lazarus, R., Celedon, J.C., Raby, B.A., Benditt, J.O., Criner,
G., Make, B., Martinez F.J dan Scanlon, P.D.2006. Genetic Association
Analysis of Functional Impairment in Chronic Obstructive Pulmonary Disease.
Am J Respir Crit Care Med, Volume 173, Nomor 9: 982.
http://www.had2know.com/academics/hardy-weinberg-equilibrium-calculator-2alleles.html. Last updated Desember, 2014.
Hudoyo, A, Sp.P. Edisi Revisi 2011. Penatalaksanaan Asma dan PPOK Pada Orang
Dewasa Berdasar Pedoman GINA (Global Initiative for Asthma) & GOLD
(Global initiative for Chronic Obstructive Lung Disease): 1-9.
Hunninghake, G.M., Cho, M.H., Tesfaigzi, Y., Soto-Quiros, M.E., Avila, L., Lasky-Su,
J., Stidley, C., Melen E., Soderhall, C., Hallberg, J., Kull, I., Kere, J.,
Universitas Sumatera Utara
Svartengren, M., Pershagen, G., Wickman, M., Lange, C., Demeo, D.L., Hersh,
C.P, Klanderman, B.J., Raby, B.A., Sparrow, D., Shapiro, S.D., Silverman, E.K.,
Litonjua, A.A., Weiss, S.T., dan Celedon, J.C. 2009. MMP12, Lung Function,
and COPD in High-Risk Population. The New England Journal of Medicine: 2,
8.
Ishii, T., Matsuse, T., Teramoto, S., Matsui, H., Miyao, M., Hosoi, T., Takahashi, H.,
Fukuchi, Y., dan Ouchi, Y. 2006. Glutathione S-transferase P1 (GSTP1)
Polymorphism in Patients with Chronic Obstructive Pulmonary Disease. Thorax,
Volume 54: 693-696.
Ito, I. et al. 2008. Matrix Metalloproteinase-9 Promoter Polymorphism Associated With
Upper Lung Dominant Emphysema. Am J Respir Crit Care Med, Volume 172:
1382.
Joshi, J.M. 2008. Chronic Obstructive Pulmonary Disease: Knowing What We Mean,
Meaning What We Say, Review Article. The Indian Journal of Chest Diseases
& Allied Sciences, Volume 50: 89-95.
Jurnal Respirologi Indonesia. 2007. Penyakit Paru Obstruktif Kronik Sebagai Penyakit
Sistemik: 1-5.
Keputusan Kementerian Kesehatan Republik Indonesia no.1022/Menkes/SK/XI/2008.
Pedoman Pengendalian Penyakit Paru Obstruktif Kronik: 11-15.
Universitas Sumatera Utara
Keputusan Kementerian Kesehatan Republik Indonesia no.1022/Menkes/SK/XI/2011.
Pedoman Pengendalian Penyakit Paru Obstruktif Kronik: 10.
Korytina, G.F., Akhmadishina, L.Z., Ianbaeva, D.G., dan Victorova, T.V. 2008.
Polymorphism in Promoter Regions of Matrix Metalloproteinases (MMP1,
MMP9, and MMP12) in Chronic Obstructive Pulmonary Disease Patients.
Russian Journal of Genetics, Volume 44: 206.
Lee, S.Y. et al. 2010. Polymorphism in Matrix Metalloproteinase-1, -9, and -12 Genes
and The Risk of Chronic Obstructive Pulmonary Disease in a Korean
Population. Respiration, Volume 80: 137.
Li, W., Jin, X., Zhou, Y., Zhu, M., Lin, X.F., Hu, X., Wang,W., Wang, F., dan Jin, G.
2012. Lack of Independent Relationship between The MMP-12 Gene
Polymorphism and Carotid Plaque Susceptibility in The Chinese Han
Population.Vascular Medicine, Volume 17, Nomor 5: 310–316.
Nakamura, H. 2011. Genetics of COPD. Allergology International, Volume 60 : 253254.
Nguyen, S.V., Skarstedt, M., Lofgren, S., Zar, N., Andersson, R.E., Lindh, M.,
Matussek, A., dan Dimberg, J. 2013. Gene Polymorphism of Matrix
Metalloproteinase-12 and -13 and Association with Colorectal Cancer in
Swedish Patients. Anticancer Research, Volume 33: 3247-3250.
Universitas Sumatera Utara
Oemiati, R. 2013. Kajian Epidemiologis Penyakit Paru Obstruktif Kronik (PPOK).
Media litbangkes, Volume 23, Nomor 2: 82-88.
Perhimpunan Dokter Paru Indonesia. 2008. Penyakit Paru Obstruktif Kronik (PPOK)
Pedoman Diagnosis & Penatalaksanaan di Indonesia: 2-6.
Santus, P. et al. 2009. Stromelysin 1 Polymorphism as a New Potential Risk Factor in
Progression of Chronic Obstructive Pulmonary Disease. Monaldi Arch Chest
Dis, Volume 71: 16.
Sastroasmoro, S dan Ismael, S. 2011. Dasar-dasar Metodologi Penelitian Klinis. Jakarta,
Penerbit Sagung Seto: 146-166.
Schirmer, H., da Silva, L.B., Teixeira, P.J.Z., Moreira, J.S., Moreira A.L.S., dan Simon,
D. 2009. Matrix Metalloproteinase Gene Polymorphisms: Lack of Association
With Chronic Pulmonary Disease in a Brazilian Population. Genetic and
Molecular Research: Volume 8: 1030-1031.
Sekhon, B.P. 2010. Matrix Metalloproteinases-an overview. Dove Medical Press,
Research and Reports in Biology, Volume 1: 1-20.
Universitas Sumatera Utara
Song, Y., Xie, Y., Liu, F., Zhao, C., Yu, R., Ban, S., Ye, Q., Wen, J., Wan, H., Li, X.,
Ma, R., dan Meng, Z. 2013. Expression of Matrix Metalloproteinase-12 in
Aortic Dissection. BioMed Central Cardiovascular Disorders: Volume 13: 3-9.
Sun, C., Wang, W., Yang, J., Siqingaowa, dan Wang, L. 2012. The Association of
Matrix metalloproteinase 3, 12 Polymorphism with Susceptibility of Chronic
Obstructive Pulmonary Disease. Chin J Clinicians (Electronic Edition), Volume
6: 5829.
Supriyadi, M. 2013. Faktor Genetik Penyakit Paru Obstruktif Kronik. CDK-207,
Volume 40, Nomor 8: 572-578.
Tacheva, T., Dimov., D., Aleksandrova, E., Gulubova, M., dan Vlaykova, T. 2014.
Common Promoter Polymorphism MMP-12 -82A/G in a Population from
Central Bulgaria. Science and Technologies Medicine, Volume 4: 140-143.
Tarigan, A.P. 2012. Hubungan Polimorfisme Gen TNFα Pada Posisi -308 dan -238
Dengan Kejadian Penyakit Paru Obstruktif Kronik. Disertasi, Program Studi
Doktor Ilmu Kedokteran, Universitas Sumatera Utara, Medan.
Teramoto, S. 2007. COPD Pathogenesis from the View Point of Risk Factors. The
Japanese Society of Internal Medicine: 77-78.
Tesfaigzi, Y., Myers, O.B., Stidley, C.A., Schwalm, K., Picchi, M., Crowell, R.E.,
Gilliland, F.D., dan Belinsky, S.A. 2006. Genotypes in Matrix Metalloproteinase
Universitas Sumatera Utara
are a Risk Factor for COPD. Int J Chron Obstruct Pulmon Dis, Volume 1,
Nomor 3: 268.
Van Diemen, C.C. et al. 2011. Genetic Variation in TIMP1 but not MMPs Predict
Excess FEV1 Decline in Two General Population-Based Cohorts. Respir Res,
Volume 12: 57.
Vlaykova, T., dan Dimov, D. 2011. Polymorphisms of Matrix Metalloproteinases
(MMP) in COPD. Biotechnology & Biotechnological Equipment, Volume 26:
116.
Wieczorek, E., Reszka, E., Jablonowski, Z., Jablonska, E., Krol, M.B., Grzegorczyk, A.,
Gromadzinska, J., Sosnowski, M., dan Wasowicz, W. 2013. Genetic
Polymorphisms in Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of
MPs (TIMPs), and Bladder Cancer Susceptibility. BJU International, Volume
112: 1211-1212.
Wood, A.M., Tan, S.L., dan Stockley, R.A. 2009. Review: Chronic Obstructive
Pulmonary Disease: Towards Pharmacogenetics. Genome medicine, Volume 1,
Nomor 112: 1-2,6.
Zitka, O., Kukacka, J., Krizkova, S., Huska, D., Adam, V., Masarik, M., Prusa, R., dan
Kizek, R. 2010. Matrix Metalloproteinase. Current Medicinal Chemistry,
Volume 17: 3751-3768.
Universitas Sumatera Utara
Zhou, H., Wu, Y., Jin, Y., Zhou, J., Zhang, C., Che, L., Jing, J., Chen, Z., Li, W., dan
Shen, H. 2013. Genetic Polymorphism of Matrix Metalloproteinase Family and
Chronic Obstructive Pulmonary Disease Susceptibility: a Meta-analysis.
Scientific Reports, Volume 3, Nomor 2818: 1-8.
Universitas Sumatera Utara